Injectable Drug Delivery Market Analysis and Forecast to 2024
ReportsWeb.com has announced the addition of the “Global Injectable Drug Delivery Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification.
(EMAILWIRE.COM, December 15, 2017 ) In this region, global injectable drug delivery is projected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024.
Based on geography, the global injectable drug delivery market is segmented into 5 geographical regions, such as,
North America,
South America,
Europe,
APAC,
MEA,
Request a Sample copy at http://www.reportsweb.com/inquiry&RW00011159381/sample
Becton Dickinson and company is going to dominate the injectable drug delivery market following with Pfizer and Baxter International, Inc., along with others such as
Gerresheimer AG,
Schott AG,
Alkermes Plc.,
Eli Lilly and Company,
Sandoz,
Terumo Corporation,
Teva Pharmaceuticals Industries Ltd.,
Bespak, Antares Pharma,
Elcam Medical,
Haselmeier,
Mylan N.V.,
Novo Nordisk,
Owen Mumford Ltd,
Sanofi,
West Pharmaceutical Services, Inc,
Ypsomed Holding AG.
Complete report is available at http://www.reportsweb.com/global-injectable-drug-delivery-market-analysis-and-forecast-to-2024
The global injectable drug delivery market is segmented into 2 types, namely injectable drug delivery device and injectable drug delivery formulation.
Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices.
The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation.
On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others.
The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn's disease, psoriasis and others.
Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others.
On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.
On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.
On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others.
Table of Contents:
Introduction
2 Market Segmentation
arket Overview
4 Executive Summary
5 Premium Insights
7 Global Aromatherapy Market, By Equipment
8 Global Aromatherapy Market, By Application
Global Aromatherapy Market, By Distribution Channel
Global Aromatherapy Market, By End User
Global Aromatherapy Market, By Geography
Global Aromatherapy Market, Company Landscape
Based on geography, the global injectable drug delivery market is segmented into 5 geographical regions, such as,
North America,
South America,
Europe,
APAC,
MEA,
Request a Sample copy at http://www.reportsweb.com/inquiry&RW00011159381/sample
Becton Dickinson and company is going to dominate the injectable drug delivery market following with Pfizer and Baxter International, Inc., along with others such as
Gerresheimer AG,
Schott AG,
Alkermes Plc.,
Eli Lilly and Company,
Sandoz,
Terumo Corporation,
Teva Pharmaceuticals Industries Ltd.,
Bespak, Antares Pharma,
Elcam Medical,
Haselmeier,
Mylan N.V.,
Novo Nordisk,
Owen Mumford Ltd,
Sanofi,
West Pharmaceutical Services, Inc,
Ypsomed Holding AG.
Complete report is available at http://www.reportsweb.com/global-injectable-drug-delivery-market-analysis-and-forecast-to-2024
The global injectable drug delivery market is segmented into 2 types, namely injectable drug delivery device and injectable drug delivery formulation.
Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices.
The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation.
On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others.
The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn's disease, psoriasis and others.
Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others.
On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.
On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.
On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others.
Table of Contents:
Introduction
2 Market Segmentation
arket Overview
4 Executive Summary
5 Premium Insights
7 Global Aromatherapy Market, By Equipment
8 Global Aromatherapy Market, By Application
Global Aromatherapy Market, By Distribution Channel
Global Aromatherapy Market, By End User
Global Aromatherapy Market, By Geography
Global Aromatherapy Market, Company Landscape
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results